| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/24/1997 | WO1997014799A1 Fibronectic binding protein b compounds |
| 04/24/1997 | WO1997014798A2 Polynucleotides and proteins coded thereby useful for controlling melolontha sp. cockchafers |
| 04/24/1997 | WO1997014797A2 Cystatin m, a novel cysteine proteinase inhibitor |
| 04/24/1997 | WO1997014796A1 Monoclonal antibody br110 and uses thereof |
| 04/24/1997 | WO1997014795A1 Tumor associated polypeptides with carboxyl-terminal alanine-proline, proline-proline or glycine-proline and antibodies thereto |
| 04/24/1997 | WO1997014794A1 ACTIVATION OF p53 PROTEIN |
| 04/24/1997 | WO1997014793A1 Nucleic acid clamps |
| 04/24/1997 | WO1997014792A2 Oligonucleotides with anti-respiratory syncytial virus activity |
| 04/24/1997 | WO1997014791A1 Animals with targeted gene deletion |
| 04/24/1997 | WO1997014789A2 Enzymatic array and process of making same |
| 04/24/1997 | WO1997014787A1 Nucleotide sequences coding for mevalonate pyrophosphate decarboxylase |
| 04/24/1997 | WO1997014786A1 RECOMBINANT α-N-ACETYLGALACTOSAMINIDASE ENZYME |
| 04/24/1997 | WO1997014782A1 Live vaccines against gram-negative pathogens, expressing heterologous o-antigens |
| 04/24/1997 | WO1997014714A1 The aiolos gene |
| 04/24/1997 | WO1997014710A1 Preparation of phosphorothioate oligomers |
| 04/24/1997 | WO1997014709A1 Antisense oligomers |
| 04/24/1997 | WO1997014706A1 Method for solution phase synthesis of oligonucleotides |
| 04/24/1997 | WO1997014440A1 Conjugation of c-myc antisense oligonucleotides with cholesterol to significantly enhance their inhibitory effect on neointimal hyperplasia |
| 04/24/1997 | WO1997014433A1 Chicken interleukin-15 and uses thereof |
| 04/24/1997 | WO1997014432A1 Modulation of integrin-mediated signal transduction |
| 04/24/1997 | WO1997014431A1 Production of recombinant procollagen in yeast |
| 04/24/1997 | WO1997014425A1 Two novel genes from psoriatic epidermis: psoriastatin type i and psoriastatin type ii |
| 04/24/1997 | WO1997014424A1 Neurological drug screens |
| 04/24/1997 | WO1997014421A1 Namenamicin, an enediyne antitumor antibiotic from the marine ascidian polysyncraton lithostrotum |
| 04/24/1997 | WO1997014290A1 Synthesis of immunologic, therapeutic and prophylactic compounds by endophytic microorganisms |
| 04/24/1997 | WO1997012044A3 Pichia secretory leader for protein expression |
| 04/24/1997 | WO1997011968A3 A gene associated with liver neoplastic disease |
| 04/24/1997 | WO1997010346A3 Removal of metals from contaminated substrates by plants |
| 04/24/1997 | WO1997009420A3 Dna sequences coding for a human metalloproteinase and variants thereof |
| 04/24/1997 | WO1997009348A3 Orphan receptor |
| 04/24/1997 | WO1997007784A3 LIPOSOMAL PHOSPHODIESTER, PHOSPHOROTHIOATE, AND p-ETHOXY OLIGONUCLEOTIDES |
| 04/24/1997 | WO1997006258A3 CDNA sequence, amino-acid sequence, derived from the CDNA sequence, of the precursor protein of human GCAP-II/uroguanyline, and amino-acid sequence of the fragment circulating in human blood |
| 04/24/1997 | WO1997005267A3 Mucosal delivery of polynucleotides |
| 04/24/1997 | WO1996040964A3 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
| 04/24/1997 | WO1996040897A3 Chondroitinase i and chondroitinase ii producing mutants of p. vulgaris |
| 04/24/1997 | WO1996038474A3 Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide |
| 04/24/1997 | WO1996034107A3 Antiviral proteins, dna coding sequences therefor, and uses thereof |
| 04/24/1997 | WO1996027665A3 Neuron-restrictive silencer factor proteins |
| 04/24/1997 | DE19642729A1 DNA encoding Bacillus popillae crystal protein |
| 04/24/1997 | CA2241835A1 Conjugation of c-myc antisense oligonucleotides with cholesterol to significantly enhance their inhibitory effect on neointimal hyperplasia |
| 04/24/1997 | CA2235075A1 Polynucleotides and the proteins encoded thereby, suitable for controlling lamellicorn beetles |
| 04/24/1997 | CA2234998A1 Xylanase, oligonucleotidic sequence encoding it and its uses |
| 04/24/1997 | CA2234877A1 Herpesvirus vectors and their uses |
| 04/24/1997 | CA2234159A1 Method for solution phase synthesis of oligonucleotides |
| 04/24/1997 | CA2232235A1 A novel human b cell surface molecule |
| 04/24/1997 | CA2232234A1 Methods for production of recombinant plasmids |
| 04/24/1997 | CA2231582A1 Enzymatic array and process of making same |
| 04/24/1997 | CA2207973A1 Modulation of integrin-mediated signal transduction |
| 04/23/1997 | EP0769696A2 Antibodies and proteins useful for assaying virus infection in grape plants |
| 04/23/1997 | EP0769560A2 Detecting genetic predisposition to periodontal disease |
| 04/23/1997 | EP0769556A1 BARLEY $g(b)-AMYLASE STRUCTURAL GENE |
| 04/23/1997 | EP0769555A1 Gene coding for glycosyltransferase and use thereof |
| 04/23/1997 | EP0769554A2 Human CNP gene and precursor protein |
| 04/23/1997 | EP0769553A1 Dna fragment, recombination vector containing the same, and method of the expression of alien gene with the use of the same |
| 04/23/1997 | EP0769552A1 Antisense nucleic acid compound |
| 04/23/1997 | EP0769551A1 Dna strand useful in increasing carotenoid yield |
| 04/23/1997 | EP0769550A2 Gene encoding endo-beta-n-acetyl glucosaminidase A |
| 04/23/1997 | EP0769549A2 Enzyme mutants having a low degree of variation of the molecular charge over a pH range |
| 04/23/1997 | EP0769149A1 Immunoassay for mycophenolic acid |
| 04/23/1997 | EP0769144A2 Assay for inhibitors of dp-1 and other dp proteins |
| 04/23/1997 | EP0769068A1 Simultaneous detection, identification and differentiation of eubacterial taxa using a hybridization assay |
| 04/23/1997 | EP0769065A1 Methods for identifying inhibitors of integrin activation |
| 04/23/1997 | EP0769063A1 Targeted gene delivery system |
| 04/23/1997 | EP0769062A2 Novel internal ribosome entry site, vector containing same and therapeutical use thereof |
| 04/23/1997 | EP0769061A1 Chimeric genes and method for increasing the threonine content of the seeds of plants |
| 04/23/1997 | EP0769060A1 Fas associated proteins |
| 04/23/1997 | EP0769059A1 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
| 04/23/1997 | EP0769058A1 Nucleic acid fragments and corresponding peptide fragments from the caprine arthritis-encephalitis virus (caev) genome, and uses thereof |
| 04/23/1997 | EP0769057A1 RECOMBINANT MONO AND POLY ANTIGENS TO DETECT CYTOMEGALOVIRUS-SPECIFIC IgM IN HUMAN SERA BY ENZYME IMMUNOASSAY |
| 04/23/1997 | EP0769056A1 NON-SPLICING VARIANTS OF gp350/220 |
| 04/23/1997 | EP0769055A1 Variants of leukemia inhibitory factor |
| 04/23/1997 | EP0769054A1 Immunomodulators |
| 04/23/1997 | EP0769053A2 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma |
| 04/23/1997 | EP0769052A2 Mammalian peroxisome proliferator-activated receptors and uses thereof |
| 04/23/1997 | EP0769051A1 Genes encoding and method of expressing a novel enzyme: phthalyl amidase |
| 04/23/1997 | EP0769025A1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown |
| 04/23/1997 | EP0769024A1 High-affinity melatonin receptors and uses thereof |
| 04/23/1997 | EP0769023A1 Retinoic acid receptor epsilon |
| 04/23/1997 | EP0769021A2 Transgenic fish in the treatment of diabetes |
| 04/23/1997 | EP0769020A1 NEW hIL-4 MUTANT PROTEINS USED AS ANTAGONISTS OR PARTIAL AGONISTS OF HUMAN INTERLEUKIN 4 |
| 04/23/1997 | EP0768894A1 Multi-stage cascade boosting vaccine |
| 04/23/1997 | EP0768893A1 Polynucleotide vaccine for papillomavirus |
| 04/23/1997 | EP0768869A1 Factor to grow tissue ex vivo |
| 04/23/1997 | EP0768824A1 Insect control method with genetically engineered biopesticides |
| 04/23/1997 | EP0768821A1 pp60PIK : A DOWNSTREAM ELEMENT IN INSULIN SIGNALING |
| 04/23/1997 | EP0749472A4 Extracorporeal cell culture and transplantation kits |
| 04/23/1997 | EP0736090A4 Oxidation-resistant muteins of beta-galactosidase fragments |
| 04/23/1997 | EP0707599B1 Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |
| 04/23/1997 | EP0673439B1 Method for detecting environmental insults |
| 04/23/1997 | EP0652973B1 Method for introducing defined sequences at the 3' end of polynucleotides |
| 04/23/1997 | EP0624196B1 Polypeptides with fibronectin binding sites as modulators for matrix assembly |
| 04/23/1997 | EP0621869B1 Human kunitz-type protease inhibitor variants |
| 04/23/1997 | EP0550549B1 Isolation of polynucleotides |
| 04/23/1997 | EP0513316B1 Analytical tracers for cancer, particularly malignant breast cancer |
| 04/23/1997 | EP0502956B1 Production of recombinant human interleukin-1 inhibitor |
| 04/23/1997 | EP0495049B1 Process for the enzymatic preparation of basic fibroblast growth factor |
| 04/23/1997 | EP0493418B1 Method of producing fusion proteins |
| 04/23/1997 | EP0401254B1 Methods for controlling norleucine content in polypeptides |
| 04/23/1997 | EP0400047B1 Modified hepatocytes and uses therefor |
| 04/23/1997 | EP0394418B1 Osteogenic factors |